Gift Opening
$200 Off MarketBeat All Access
Thanks for being one of our best subscribers! You are eligible for a limited-time discount.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
Claim Your Discount
×
Free Trial
Thank you for registering! Take a moment to confirm your subscription to MarketBeat Daily Ratings so that you can access MarketBeat's tools, reports, and news. Please click the "Send Confirmation Email" button and we'll send you an email with confirmation instructions.

Ikena Oncology (IKNA) SEC Filings & 10K Form

$1.43
+0.03 (+2.14%)
(As of 05/17/2024 08:53 PM ET)

Recent Ikena Oncology SEC Filings

DateFilerForm TypeView
05/13/2024
3:33 PM
Ikena Oncology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/26/2024
3:22 PM
Ikena Oncology (Filer)
Form DEF 14A
03/12/2024
6:48 AM
Ikena Oncology (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/12/2024
6:30 AM
Ikena Oncology (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/11/2024
7:19 AM
FMR LLC (Filed by)
Ikena Oncology (Subject)
Form SC 13G/A
02/21/2024
3:29 PM
Ikena Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
3:57 PM
CITADEL ADVISORS LLC (Filed by)
Ikena Oncology (Subject)
Form SC 13G/A
Shocking $16T Elon Musk Crypto Leak (Ad)

Reports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.

Click here now to get your copy.
02/14/2024
8:47 AM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Ikena Oncology (Subject)
Form SC 13G/A
02/09/2024
8:16 AM
Ikena Oncology (Subject)
Form SC 13G/A
02/02/2024
4:15 PM
Ecsedy Jeffrey (Reporting)
Ikena Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
4:07 PM
Ikena Oncology (Issuer)
Manfredi Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
4:08 PM
Ikena Oncology (Issuer)
Marango Jotin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2024
3:26 PM
Ikena Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/09/2023
6:09 AM
Ikena Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/09/2023
6:30 AM
Ikena Oncology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/19/2023
2:33 PM
GILEAD SCIENCES, INC. (Filed by)
Ikena Oncology (Subject)
Form SC 13G
10/11/2023
4:10 PM
Ikena Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/25/2023
3:05 PM
Ikena Oncology (Filer)
Form DEF 14A
09/21/2023
4:02 PM
Ikena Oncology (Issuer)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VI LLC (Reporting)
OrbiMed Genesis GP LLC (Reporting)
Form 4/A
09/21/2023
4:04 PM
Bonita David P (Reporting)
Ikena Oncology (Issuer)
Form 4/A
09/21/2023
3:52 PM
Ikena Oncology (Subject)
ORBIMED ADVISORS LLC (Filed by)
Form SC 13D/A
09/15/2023
3:05 PM
Ikena Oncology (Filer)
Form PRE 14A
09/14/2023
8:22 PM
Ikena Oncology (Issuer)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VI LLC (Reporting)
OrbiMed Genesis GP LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/14/2023
8:17 PM
Bonita David P (Reporting)
Ikena Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/14/2023
3:21 PM
Ikena Oncology (Subject)
ORBIMED ADVISORS LLC (Filed by)
Form SC 13D/A
09/12/2023
3:11 PM
Ikena Oncology (Filer)
Form 424B5
09/10/2023
11:15 PM
Ikena Oncology (Filer)
Form EFFECT
08/10/2023
6:00 AM
Ikena Oncology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/07/2023
7:02 AM
Ikena Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/30/2023
4:15 PM
Ikena Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/13/2023
3:30 PM
FORMELA JEAN FRANCOIS (Reporting)
Ikena Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2023
3:30 PM
Ikena Oncology (Issuer)
Wooster Richard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2023
3:30 PM
Bonita David P (Reporting)
Ikena Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2023
3:30 PM
Ikena Oncology (Issuer)
Koehler Maria (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2023
3:30 PM
Ikena Oncology (Issuer)
Stampacchia Otello (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2023
3:30 PM
Hughes Owen (Reporting)
Ikena Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2023
3:30 PM
Dukes Iain D. (Reporting)
Ikena Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:IKNA) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners